SR ONE CAPITAL MANAGEMENT, LP
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CRISPR Therapeutics AG(CRSP) | 1,048,951 | 2,038,763 | +989,812 | 51,020,977 | 132,132,230 | 19.11% | +81,111,253 |
| Zenas BioPharma, Inc(ZBIO) | 4,911,539 | 4,911,539 | 0 | 47,592,813 | 109,036,166 | 15.77% | +61,443,353 |
| Arcellx, Inc. | 2,346,630 | 2,346,630 | 0 | 154,525,586 | 192,658,323 | 27.86% | +38,132,737 |
| Mineralys Therapeutics Inc.(MLYS) | 3,127,933 | 2,113,933 | -1,014,000 | 42,320,934 | 80,160,339 | 11.59% | +37,839,405 |
| Design Therapeutics, Inc. | 6,526,476 | 6,526,476 | 0 | 21,994,224 | 49,144,364 | 7.11% | +27,150,140 |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,514,929 | 4,514,929 | 0 | 45,826,529 | 54,179,148 | 7.84% | +8,352,619 |
| Oruka Therapeutics, Inc(ORKA) | 430,330 | 430,330 | 0 | 4,823,999 | 8,275,246 | 1.20% | +3,451,247 |
| enGene Holdings Inc. | 747,750 | 747,750 | 0 | 2,721,810 | 5,107,133 | 0.74% | +2,385,323 |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | 5,879,688 | 7,819,985 | 1.13% | +1,940,297 |
| Nkarta, Inc. | 3,333,333 | 3,333,333 | 0 | 5,533,333 | 6,899,999 | 1.00% | +1,366,666 |
| Oculis Holding AG | 322,500 | 322,500 | 0 | 6,259,725 | 5,669,550 | 0.82% | -590,175 |
| KALA Bio, Inc. | 598,940 | 0 | -598,940 | 2,850,954 | 0 | — | -2,850,954 |
| ARS Pharmaceuticals, Inc. | 4,012,903 | 4,012,903 | 0 | 70,025,157 | 40,329,675 | 5.83% | -29,695,482 |